Literature DB >> 34505526

High cysteine diet reduces insulin resistance in SHR-CRP rats.

J Krijt1, J Sokolová, J Šilhavý, P Mlejnek, J Kubovčiak, F Liška, H Malínská, M Hüttl, I Marková, M Křížková, M H Stipanuk, T Křížek, T Ditroi, P Nagy, V Kožich, M Pravenec.   

Abstract

Increased plasma total cysteine (tCys) has been associated with obesity and metabolic syndrome in human and some animal studies but the underlying mechanisms remain unclear. In this study, we aimed at evaluating the effects of high cysteine diet administered to SHR-CRP transgenic rats, a model of metabolic syndrome and inflammation. SHR-CRP rats were fed either standard (3.2 g cystine/kg diet) or high cysteine diet (HCD, enriched with additional 4 g L-cysteine/kg diet). After 4 weeks, urine, plasma and tissue samples were collected and parameters of metabolic syndrome, sulfur metabolites and hepatic gene expression were evaluated. Rats on HCD exhibited similar body weights and weights of fat depots, reduced levels of serum insulin, and reduced oxidative stress in the liver. The HCD did not change concentrations of tCys in tissues and body fluids while taurine in tissues and body fluids, and urinary sulfate were significantly increased. In contrast, betaine levels were significantly reduced possibly compensating for taurine elevation. In summary, increased Cys intake did not induce obesity while it ameliorated insulin resistance in the SHR-CRP rats, possibly due to beneficial effects of accumulating taurine.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34505526      PMCID: PMC8820534          DOI: 10.33549/physiolres.934736

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  35 in total

1.  Downregulation of hepatic betaine:homocysteine methyltransferase (BHMT) expression in taurine-deficient mice is reversed by taurine supplementation in vivo.

Authors:  Halina Jurkowska; Julie Niewiadomski; Lawrence L Hirschberger; Heather B Roman; Kevin M Mazor; Xiaojing Liu; Jason W Locasale; Eunkyue Park; Martha H Stipanuk
Journal:  Amino Acids       Date:  2015-10-20       Impact factor: 3.520

2.  In vivo regulation of cysteine dioxygenase via the ubiquitin-26S proteasome system.

Authors:  John E Dominy; Lawrence L Hirschberger; Relicardo M Coloso; Martha H Stipanuk
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  Cysteine and obesity.

Authors:  Amany K Elshorbagy; A David Smith; Viktor Kozich; Helga Refsum
Journal:  Obesity (Silver Spring)       Date:  2011-05-05       Impact factor: 5.002

4.  Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.

Authors:  L El-Khairy; P M Ueland; O Nygård; H Refsum; S E Vollset
Journal:  Am J Clin Nutr       Date:  1999-12       Impact factor: 7.045

Review 5.  Cysteine and obesity: consistency of the evidence across epidemiologic, animal and cellular studies.

Authors:  Amany K Elshorbagy; Viktor Kozich; A David Smith; Helga Refsum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-01       Impact factor: 4.294

Review 6.  The sulfur-containing amino acids: an overview.

Authors:  John T Brosnan; Margaret E Brosnan
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

Review 7.  Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur.

Authors:  Martha H Stipanuk; Iori Ueki
Journal:  J Inherit Metab Dis       Date:  2010-02-17       Impact factor: 4.982

8.  Impact of taurine depletion on glucose control and insulin secretion in mice.

Authors:  Takashi Ito; Natsumi Yoshikawa; Hiromi Ito; Stephen W Schaffer
Journal:  J Pharmacol Sci       Date:  2015-09-01       Impact factor: 3.337

9.  Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice.

Authors:  Ryan D Welch; Cyrielle Billon; Amina Kameric; Thomas P Burris; Colin A Flaveny
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

10.  Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study.

Authors:  Thomas Olsen; Bente Øvrebø; Nadia Haj-Yasein; Sindre Lee; Karianne Svendsen; Marit Hjorth; Nasser E Bastani; Frode Norheim; Christian A Drevon; Helga Refsum; Kathrine J Vinknes
Journal:  J Transl Med       Date:  2020-03-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.